Switch to
| Predicate | Object |
|---|---|
| rdf:type | |
| lifeskim:mentions | |
| pubmed:dateCreated |
1980-9-23
|
| pubmed:language |
eng
|
| pubmed:journal | |
| pubmed:citationSubset |
IM
|
| pubmed:chemical | |
| pubmed:status |
MEDLINE
|
| pubmed:issn |
0065-2229
|
| pubmed:author | |
| pubmed:issnType |
Print
|
| pubmed:volume |
23
|
| pubmed:owner |
NLM
|
| pubmed:authorsComplete |
Y
|
| pubmed:pagination |
245-53
|
| pubmed:dateRevised |
2004-11-17
|
| pubmed:meshHeading |
pubmed-meshheading:7395614-Bromocriptine,
pubmed-meshheading:7395614-Dose-Response Relationship, Drug,
pubmed-meshheading:7395614-Drug Administration Schedule,
pubmed-meshheading:7395614-Humans,
pubmed-meshheading:7395614-Levodopa,
pubmed-meshheading:7395614-Middle Aged,
pubmed-meshheading:7395614-Parkinson Disease
|
| pubmed:year |
1980
|
| pubmed:articleTitle |
Bromocriptine in Parkinson's disease: report on 106 patients treated for up to 5 years.
|
| pubmed:publicationType |
Journal Article
|